Located within CSLB’s GSPV department, the Director, Global Safety Lead, Formulation Safety provide expertise on all aspects of –clinical safety throughout the entire lifecycle of a product with special emphasis on ongoing evaluation of safety information
Overview: The Manager, Clinical Trial Authorization (CTA) is responsible for ensuring that CTA activities for assigned clinical studies are planned, governed, and overseen in line with CSL regulatory expectations, quality standards, and development timelines. Reporting to
The Senior Statistical Programmer is responsible for providing hands-on support and technical guidance on clinical study teams. The development of study and ad hoc output, including, but not limited to: ADaM datasets, tables, figures, and listings
Jobdescription On behalf of our client, a prestigious, highly respected Swiss corporate group with deep roots in the premium healthcare and service sector, we are searching for an analytical, delivery-focused Group Accountant (80-100%). Based in their modern
The Director Non-Clinical Due Diligence & External Evaluations provides scientific leadership for nonclinical due diligence supporting CSL’s in‑licensing, acquisitions, and strategic collaborations. The role ensures integrated, objective, and decision‑relevant evaluations of nonclinical pharmacology, PK/QSP, and toxicology
The Opportunity: The Sr. Director, Head of Global Labeling Strategy leads the Global Labeling strategy function within Global Labeling, Advertising & Promotion and has overall responsibility for the worldwide labeling strategy portfolio within CSL. In this
CSLs R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we’re building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means
Responsibilities • Creating and leading a high-performing cross-functional team of global functional senior leaders responsible for the delivery of the product portfolio • Creating ambitious development plans and options for each of their assets, with the